AstraZeneca PLC - stock earnings
AZN.ST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 9.7 billion SEK | 121.1 billion SEK |
| 2023Q3 | 15.0 billion SEK | 125.5 billion SEK |
| 2023Q2 | 19.7 billion SEK | 123.9 billion SEK |
| 2023Q1 | 18.7 billion SEK | 112.7 billion SEK |
| 2022Q4 | 9.4 billion SEK | 116.7 billion SEK |
| 2022Q3 | 18.3 billion SEK | 122.7 billion SEK |
| 2022Q2 | 3.7 billion SEK | 110.0 billion SEK |
| 2022Q1 | 3.6 billion SEK | 105.5 billion SEK |
| 2021Q4 | -3.1 billion SEK | 108.7 billion SEK |
| 2021Q3 | -14.5 billion SEK | 86.4 billion SEK |
| 2021Q2 | 4.7 billion SEK | 70.3 billion SEK |
| 2021Q1 | 13.6 billion SEK | 63.9 billion SEK |
| 2020Q4 | 8.4 billion SEK | 61.2 billion SEK |
| 2020Q3 | 5.8 billion SEK | 58.9 billion SEK |
| 2020Q2 | 7.0 billion SEK | 58.5 billion SEK |
| 2020Q1 | 7.8 billion SEK | 63.7 billion SEK |
| 2019Q4 | 2.9 billion SEK | 62.3 billion SEK |
| 2019Q3 | 2.9 billion SEK | 62.6 billion SEK |
| 2019Q2 | 1.2 billion SEK | 54.0 billion SEK |
| 2019Q1 | 5.5 billion SEK | 51.0 billion SEK |
| 2018Q4 | 9.3 billion SEK | 57.6 billion SEK |
| 2018Q3 | 3.8 billion SEK | 47.3 billion SEK |
| 2018Q2 | 3.2 billion SEK | 46.6 billion SEK |
| 2018Q1 | 2.8 billion SEK | 43.3 billion SEK |
| 2017Q4 | 10.7 billion SEK | 47.6 billion SEK |
| 2017Q3 | 5.6 billion SEK | 50.6 billion SEK |
| 2017Q2 | 4.0 billion SEK | 42.7 billion SEK |
| 2017Q1 | 4.8 billion SEK | 48.3 billion SEK |
| 2016Q4 | 16.7 billion SEK | 50.7 billion SEK |
| 2016Q3 | 8.7 billion SEK | 48.9 billion SEK |
| 2016Q2 | -25.3 million SEK | 47.3 billion SEK |
| 2016Q1 | 5.3 billion SEK | 49.7 billion SEK |
| 2015Q4 | 6.8 billion SEK | 53.8 billion SEK |
| 2015Q3 | 6.4 billion SEK | 49.8 billion SEK |
| 2015Q2 | 5.7 billion SEK | 51.9 billion SEK |
| 2015Q1 | 4.7 billion SEK | 52.0 billion SEK |
| 2014Q4 | -2.5 billion SEK | 51.8 billion SEK |
| 2014Q3 | 1.8 billion SEK | 47.3 billion SEK |
| 2014Q2 | 5.4 billion SEK | 43.5 billion SEK |
| 2014Q1 | 3.3 billion SEK | 41.7 billion SEK |
| 2013Q4 | -3.4 billion SEK | 43.9 billion SEK |
| 2013Q3 | 8.0 billion SEK | 40.2 billion SEK |
| 2013Q2 | 5.5 billion SEK | 42.0 billion SEK |
| 2013Q1 | 6.6 billion SEK | 41.6 billion SEK |
| 2012Q4 | 9.9 billion SEK | 47.4 billion SEK |
| 2012Q3 | 10.0 billion SEK | 43.6 billion SEK |
| 2012Q2 | 11.3 billion SEK | 46.9 billion SEK |
| 2012Q1 | 10.9 billion SEK | 48.9 billion SEK |
| 2011Q4 | 10.2 billion SEK | 59.6 billion SEK |
| 2011Q3 | 23.7 billion SEK | 55.9 billion SEK |
| 2011Q2 | 13.4 billion SEK | 53.3 billion SEK |
| 2011Q1 | 18.4 billion SEK | 52.4 billion SEK |
| 2010Q4 | 10.9 billion SEK | 58.1 billion SEK |
| 2010Q3 | 10.4 billion SEK | 53.0 billion SEK |
| 2010Q2 | 16.4 billion SEK | 63.7 billion SEK |
| 2010Q1 | 20.0 billion SEK | 61.9 billion SEK |
| 2009Q4 | 11.1 billion SEK | 64.0 billion SEK |
| 2009Q3 | 14.7 billion SEK | 57.0 billion SEK |
| 2009Q2 | 13.1 billion SEK | 61.3 billion SEK |
| 2009Q1 | 17.7 billion SEK | 63.5 billion SEK |
| 2008Q4 | 9.8 billion SEK | 64.2 billion SEK |
| 2008Q3 | 12.0 billion SEK | 53.7 billion SEK |
| 2008Q2 | 9.7 billion SEK | 47.9 billion SEK |
| 2008Q1 | 8.9 billion SEK | 45.7 billion SEK |
| 2007Q4 | 8.2 billion SEK | 52.8 billion SEK |
| 2007Q3 | 8.6 billion SEK | 46.0 billion SEK |
| 2007Q2 | 9.7 billion SEK | 49.7 billion SEK |
| 2007Q1 | 10.9 billion SEK | 48.6 billion SEK |
| 2006Q4 | 9.8 billion SEK | 48.9 billion SEK |
| 2006Q3 | 11.6 billion SEK | 47.7 billion SEK |
| 2006Q2 | 11.5 billion SEK | 47.7 billion SEK |
| 2006Q1 | 11.1 billion SEK | 48.2 billion SEK |
| 2005Q4 | 9.7 billion SEK | 49.9 billion SEK |
| 2005Q3 | 9.5 billion SEK | 44.8 billion SEK |
| 2005Q2 | 9.5 billion SEK | 47.9 billion SEK |
| 2005Q1 | 7.4 billion SEK | 40.6 billion SEK |
| 2004Q4 | 7.1 billion SEK | 38.5 billion SEK |
| 2004Q3 | 8.2 billion SEK | 38.3 billion SEK |
| 2004Q2 | 6.1 billion SEK | 39.8 billion SEK |
| 2004Q1 | 6.0 billion SEK | 38.3 billion SEK |
| 2003Q4 | 4.6 billion SEK | 35.1 billion SEK |
| 2003Q3 | 6.2 billion SEK | 37.0 billion SEK |
| 2003Q2 | 5.4 billion SEK | 35.8 billion SEK |
| 2003Q1 | 7.9 billion SEK | 40.2 billion SEK |
| 2002Q4 | 3.8 billion SEK | 41.2 billion SEK |
| 2002Q3 | 6.1 billion SEK | 39.7 billion SEK |
| 2002Q2 | 7.1 billion SEK | 39.2 billion SEK |
| 2002Q1 | 9.9 billion SEK | 45.8 billion SEK |
| 2001Q4 | 20.8 billion SEK | 121.4 billion SEK |
| 2001Q3 | 7.6 billion SEK | 42.0 billion SEK |
| 2001Q2 | 7.5 billion SEK | 44.6 billion SEK |
| 2001Q1 | 8.1 billion SEK | 41.2 billion SEK |
| 2000Q4 | 5.2 billion SEK | 61.3 billion SEK |
| 2000Q3 | 6.3 billion SEK | 36.6 billion SEK |
| 2000Q2 | 6.0 billion SEK | 35.0 billion SEK |
| 2000Q1 | 5.7 billion SEK | 33.7 billion SEK |
| 1999Q4 | -1.5 billion SEK | 43.6 billion SEK |
| 1999Q3 | 5.0 billion SEK | 44.3 billion SEK |
| 1999Q2 | 4.3 billion SEK | 46.8 billion SEK |
| 1999Q1 | 4.3 billion SEK | 46.8 billion SEK |
| 1998Q4 | 2.1 billion SEK | 19.5 billion SEK |
| 1998Q3 | 2.4 billion SEK | 24.1 billion SEK |
| 1998Q2 | 3.8 billion SEK | 25.0 billion SEK |
| 1998Q1 | 3.8 billion SEK | 25.0 billion SEK |
| 1997Q4 | 3.3 billion SEK | 23.7 billion SEK |
| 1997Q3 | 3.1 billion SEK | 21.7 billion SEK |
| 1997Q2 | 3.9 billion SEK | 23.7 billion SEK |
| 1997Q1 | 3.9 billion SEK | 23.7 billion SEK |
| 1996Q4 | 6.5 billion SEK | 47.2 billion SEK |
| 1996Q3 | 2.4 billion SEK | 24.0 billion SEK |
| 1996Q2 | 3.3 billion SEK | 23.6 billion SEK |
| 1996Q1 | 3.3 billion SEK | 23.6 billion SEK |
| 1995Q4 | 1.3 billion SEK | 18.3 billion SEK |
| 1995Q3 | 1.4 billion SEK | 20.0 billion SEK |
| 1995Q2 | 2.8 billion SEK | 20.9 billion SEK |
| 1995Q1 | 2.8 billion SEK | 20.9 billion SEK |
| 1994Q4 | 3.4 billion SEK | 18.9 billion SEK |
| 1994Q3 | 1.8 billion SEK | 18.2 billion SEK |
| 1994Q2 | 3.6 billion SEK | 19.0 billion SEK |
| 1994Q1 | 2.0 billion SEK | 19.0 billion SEK |
| 1993Q4 | 1.3 billion SEK | 15.9 billion SEK |
| 1993Q3 | 1.4 billion SEK | 15.9 billion SEK |
| 1993Q2 | 2.0 billion SEK | 18.1 billion SEK |
| 1993Q1 | 2.0 billion SEK | 18.1 billion SEK |
AZN.ST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 60.0 billion SEK | 461.4 billion SEK |
| 2022 | 34.2 billion SEK | 461.9 billion SEK |
| 2021 | 1.0 billion SEK | 338.5 billion SEK |
| 2020 | 26.4 billion SEK | 220.0 billion SEK |
| 2019 | 12.5 billion SEK | 227.9 billion SEK |
| 2018 | 19.4 billion SEK | 198.4 billion SEK |
| 2017 | 24.7 billion SEK | 185.2 billion SEK |
| 2016 | 31.8 billion SEK | 209.0 billion SEK |
| 2015 | 23.8 billion SEK | 207.8 billion SEK |
| 2014 | 9.6 billion SEK | 202.2 billion SEK |
| 2013 | 16.4 billion SEK | 164.8 billion SEK |
| 2012 | 41.0 billion SEK | 182.0 billion SEK |
| 2011 | 68.8 billion SEK | 231.4 billion SEK |
| 2010 | 54.3 billion SEK | 224.4 billion SEK |
| 2009 | 53.8 billion SEK | 234.6 billion SEK |
| 2008 | 47.8 billion SEK | 247.7 billion SEK |
| 2007 | 36.1 billion SEK | 190.9 billion SEK |
| 2006 | 41.3 billion SEK | 180.9 billion SEK |
| 2005 | 37.4 billion SEK | 190.1 billion SEK |
| 2004 | 25.3 billion SEK | 142.2 billion SEK |
| 2003 | 21.9 billion SEK | 135.8 billion SEK |
| 2002 | 24.8 billion SEK | 156.0 billion SEK |
| 2001 | 43.9 billion SEK | 248.8 billion SEK |
| 2000 | 24.0 billion SEK | 171.3 billion SEK |
| 1999 | 9.7 billion SEK | 157.1 billion SEK |
| 1998 | 12.3 billion SEK | 94.7 billion SEK |
| 1997 | 12.5 billion SEK | 88.9 billion SEK |
| 1996 | 11.4 billion SEK | 95.1 billion SEK |
| 1995 | 5.4 billion SEK | 78.4 billion SEK |
| 1994 | 7.2 billion SEK | 72.5 billion SEK |
| 1993 | 6.6 billion SEK | 68.0 billion SEK |
| 1992 | 1.3 billion SEK | 62.5 billion SEK |
| 1991 | 6.7 billion SEK | 76.1 billion SEK |
| 1990 | 4.4 billion SEK | 76.1 billion SEK |
AZN.ST
Price: SEK1,634
52 week price:
Dividend Yield: 0.00%
5-year range yield:
Forward Dividend Yield: 2.53%
Payout Ratio: 102.20%
Payout Ratio Range:
Dividend Per Share: 41.30 SEK
Earnings Per Share: 40.41 SEK
P/E Ratio: 34.93
Exchange: STO
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 2.2 trillion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 4.77%
DGR5: 6.68%
DGR10: 5.57%
DGR20: 9.04%